US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

12.540
+0.320+2.62%

Close Nov 22 16:00 ET

12.540
0.0000.00%

Post 16:20 ET

730.17MMarket Cap-4415P/E (TTM)

Cullinan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cullinan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Cullinan Therapeutics Earnings Reports

Cullinan Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 07:23 ET

Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Nov 7 07:08 ET

Cullinan Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:24 ET

Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Aug 8 07:19 ET

Analyst Rating

Updated: Nov 18, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall